The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William Schelman, MD, PhD
Hutchmed
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Peninsula Private Hospital
Frankston, Victoria, Australia
- the Perth Blood Institute (pbi) Hollywood Specialist Centre
West Perth, Western Australia, Australia
- Royal Adelaide Hospital
Adelaide, Australia
- Canberra Hospital
Canberra, Australia
- Charite University
Berlin, Germany
- Marien Hospital Dusseldorf
Düsseldorf, Germany
- Umg Gottingen Hämatologie
Göttingen, Germany
- University Hospital of Schleswig-Holstein, Department of Haematology and Oncology
Lübeck, Germany
- Sykehuset Ostfold Kalnes (fosta) / Osfold Hospital Trust (msl)
Grålum, Norway
- Oslo University Hospital
Oslo, Norway
- Hospital Universitari Vall D'Hebron
Barcelona, Spain
- Hospital del Mar Barcelona
Barcelona, Spain
- University de Burgos
Burgos, Spain
- Clinica Universidad de Navarra
Madrid, Spain
- Fundacion Jimenez Diaz
Madrid, Spain
- Hospital Gregorio Maranon Madrid
Madrid, Spain
- Hospital Infanta Leonor
Madrid, Spain
- Hospital Morales Meseguer
Murcia, Spain
- Childrens Hospital of California
Irvine, California, United States
- Georgetown University Medical Center - Georgetown Lombardi Comprehensive Cancer Center
Georgetown, Delaware, United States
- Center for Cancer and Blood Disorders
Bethesda, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- San Juan Oncology Associates
Farmington, New Mexico, United States
- East Carolina University, Brody School of Medicine
Greenville, North Carolina, United States
- Taussig Cancer Institute
Cleveland, Ohio, United States
- Oklahoma Cancer Specialists and Research Institute
Tulsa, Oklahoma, United States
- Texas Oncology San Antonio Medical Center
San Antonio, Texas, United States
- University of Washington (uw) Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Apr 2024
- Primary completion
- 30 Apr 2026
- Completion
- 30 Nov 2026
- Last update posted
- 16 Sept 2025
- Registered enrollment
- 0
- Registry id
- NCT06291415
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.